TAAV is advancing gene therapy by offering neDNA™ enzymatic, linear, double stranded DNA as the new industry standard for transfection-based AAV production. We believe it is a safer, more effective, more scalable and faster way to manufacture AAV.
Location: Spain, Autonomous Community of the Basque Country, San Sebastián
Employees: 51-200
Founded date: 2019
Mentions in press and media 1
| Date | Title | Description |
| 16.03.2023 | rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply, Upcoming Webinar Hosted by Xtalks | The manufacture of rAAV continues to be challenged to incorporate faster, safer, scalable and cheaper critical starting material and manufacturing processes to meet timelines and regulatory demands. TORONTO (PRWEB) March 16, 2023 The gene t... |